Breast cancer treatment choice help for women 70 and older
Part of Cancer, Skin clinical trials.
This study tests a decision aid to help women 70 and older with early stage breast cancer choose their treatment. It looks at whether the tool helps patients and their doctors make a confident treatment choice.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman age 70 or older.
- You have been diagnosed with a first invasive breast cancer that is smaller than 2 cm and has not spread to lymph nodes.
- Your cancer is estrogen receptor positive (ER+) and HER2 negative.
- You speak English or Spanish.
- You are scheduled to see a participating surgeon for the first time about this cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a decision aid to help women newly diagnosed with breast cancer choose between different surgery options. It looks at how well this tool supports you in making a choice that fits your values and preferences.
This study is testing a new tool to help women with early-stage breast cancer decide between lumpectomy (removing just the tumor) or mastectomy (removing the entire breast). The tool is designed for women who have not yet talked to a surgeon about their options.
This study tests a tool called BREASTChoice AIM1-B, which helps people who have had breast surgery make informed choices about their follow-up care. You may be eligible if you had a mastectomy or lumpectomy in the past 8 years for breast cancer or to lower your risk.
This study looks at how often older breast cancer survivors (80+) should get mammograms. It aims to make screening more personalized so women get the right amount of imaging.
This study tests a decision-aid tool that may help people better decide whether to take part in breast cancer screening. It targets women who are invited for screening and the general practitioners linked to them.
This study helps patients with HER2-negative metastatic breast cancer (cancer that has spread beyond the breast) make informed treatment choices together with their doctors. The trial focuses on how shared decision-making—where you and your care team discuss options together—affects your care experience and outcomes.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.